Natera, Inc. ($NTRA) Stock Forecast: Down 5.3% Today

What is Natera, Inc.?

A healthcare company specializing in genetic testing services, Natera (NTRA), has seen bearish market sentiment today.

Why is Natera, Inc. going down?

NTRA stock is down 5.3% on Dec 18, 2024 20:24

• Despite the "Golden Cross" signal indicating a bullish trend, Natera (NTRA) has faced bearish movement recently.
• While surpassing the resistance at the 20-day simple moving average could signal short-term bullish momentum, today's bearish movement suggests other influencing factors.
• Factors such as broader market conditions, company-specific news, or profit-taking activities may be contributing to the downward pressure on Natera's stock price.
• Traders should consider technical signals and external factors when deciding on transactions involving Natera (NTRA) in the current market climate.

NTRA Price Chart

NTRA Technical Analysis

NTRA News

Natera ( NTRA ) Just Flashed Golden Cross Signal: Do You Buy?

Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?

https://www.zacks.com/stock/news/2384530/natera-ntra-just-flashed-golden-cross-signal-do-you-buy

Trending Today

Hedera Hashgraph ($HBAR) Crypto Forecast: Up 5.2% Today

Horizen ($ZEN) Crypto Forecast: Up 7.6% Today

Algorand ($ALGO) Crypto Forecast: Up 10.7% Today

Aave ($AAVE) Crypto Forecast: Up 10.5% Today

Injective ($INJ) Crypto Forecast: Up 5.7% Today

Toncoin ($TON) Crypto Forecast: Up 5.4% Today

NEO ($NEO) Crypto Forecast: Up 5.1% Today

Floki ($FLOKI) Crypto Forecast: Up 5.1% Today

Pepe ($PEPE) Crypto Forecast: Up 5.3% Today

Litecoin ($LTC) Crypto Forecast: Up 5.0% Today

Natera, Inc. Price History

13.10.2024 - NTRA Stock was up 15.7%

• Natera (NTRA) reported a Q3 loss but exceeded revenue estimates, which may have positively influenced investor sentiment.
• The bullish position taken by investors in the options market indicates confidence in Natera's future performance.
• The combination of beating revenue estimates and positive investor sentiment from the options market likely contributed to the strong bullish movement in Natera's stock today.

19.06.2024 - NTRA Stock was down 5.1%

• The CEO selling over $600k in company stock might have signaled a lack of confidence in the company's future prospects, leading to a bearish sentiment among investors.
• Despite Natera's strong historical performance outperforming the market over the past 5 years, the recent insider selling could have eroded investor trust in the company's growth potential.
• The market may be reacting negatively to the CEO's decision to offload a substantial amount of company stock, causing a sell-off and driving the stock price down significantly today.

13.10.2024 - NTRA Stock was up 17.2%

• Natera (NTRA) stock experienced a strong bullish movement following the release of its third-quarter financial results.
• Analysts increased their forecasts for Natera after the company reported a quarterly loss that was lower than expected and topped revenue estimates.
• The options market also indicated a bullish sentiment towards Natera, with significant funds taking a positive position in the company.
• The positive performance of Natera stock could be attributed to the company's strong financial results and optimistic revenue guidance for the future, leading to increased investor confidence and driving the stock price higher.

18.11.2024 - NTRA Stock was down 5.3%

• Despite the "Golden Cross" signal indicating a bullish trend, Natera (NTRA) has faced bearish movement recently.
• While surpassing the resistance at the 20-day simple moving average could signal short-term bullish momentum, today's bearish movement suggests other influencing factors.
• Factors such as broader market conditions, company-specific news, or profit-taking activities may be contributing to the downward pressure on Natera's stock price.
• Traders should consider technical signals and external factors when deciding on transactions involving Natera (NTRA) in the current market climate.

05.05.2024 - NTRA Stock was up 5.2%

• Natera (NTRA) saw a strong bullish movement in the market recently.
• This positive trend is linked to Natera's upgraded initial 2024 guidance in Q1, pointing towards promising growth opportunities ahead.
• Some initial market uncertainty arose from the selling of shares by directors Gail Marcus and Rowan Chapman. However, the overall positive market outlook and raised guidance overshadowed these concerns.
• The decrease in short interest in Natera also played a role in the upward movement, reflecting a decline in bearish sentiment among investors.

10.04.2024 - NTRA Stock was up 11.9%

• Natera's stock reached a three-year peak post strong first-quarter earnings that exceeded market forecasts.
• The market's upbeat attitude towards Natera may stem from the increasing importance of genomics in healthcare, with Natera leading the way in uncovering genetic insights for better health outcomes.
• Natera's stock rally could also be linked to the general market optimism, as seen with other genomics companies posting significant gains.
• Investors are eyeing Natera for its strong performance and growth prospects in the expanding genomics market, expected to see substantial growth by 2033.

10.04.2024 - NTRA Stock was up 12.3%

• Natera's stock saw a strong bullish movement today, rising significantly in pre-market trading.
• The surge in Natera's stock price can be attributed to the company's strong first-quarter earnings report, where they outperformed market expectations with a lower-than-expected GAAP loss per share and higher-than-anticipated quarterly sales.
• The positive earnings report showcases Natera's continued growth and success in the genomics industry, positioning them as a key player in unlocking the potential of genetic testing and personalized medicine.
• The revelation of Natera's CFO selling over $175k in company stock might have raised some eyebrows, but it did not seem to deter investors who were impressed by the company's financial performance and growth prospects.

18.06.2024 - NTRA Stock was down 5.2%

• The bearish movement in Natera's stock could be attributed to the CEO selling over $600k in company stock.
• Investors may interpret the CEO's decision to sell a substantial amount of company stock as a lack of faith in the company's potential for growth or profitability in the near term.
• The market's reaction to the CEO's stock sale could indicate a loss of confidence among investors leading to a sell-off of Natera's shares and contributing to the bearish movement in the stock price today.

30.06.2024 - NTRA Stock was down 5.2%

• The bearish movement in NTRA stock could be attributed to the CFO and the president of clinical diagnostics selling significant amounts of company shares, possibly raising concerns among investors about the company's future performance.
• Despite the positive news about the validation of Natera's Signatera test for Merkel Cell Carcinoma, the focus on insider selling might have overshadowed the positive developments in the company.
• Investors might be cautious about the upcoming earnings report, even though Natera is expected to beat earnings estimates. The uncertainty surrounding the stock could have led to profit-taking and contributed to the bearish movement.
• The market might be reacting to the overall selling pressure from company insiders, leading to a negative sentiment towards Natera's stock despite the promising clinical utility of their products.

06.07.2024 - NTRA Stock was up 5.5%

• Participation in a growth conference likely sparked investor interest and confidence in the company's future prospects.
• A presentation by the leadership team may have highlighted innovative strategies and growth opportunities, leading to increased optimism among investors.
• The availability of a live webcast could have provided further insights into advancements in cell-free DNA testing, potentially attracting more attention from the investment community.

07.07.2024 - NTRA Stock was up 6.3%

• Natera has outperformed the market significantly over the past 5 years, showcasing strong growth prospects and investor confidence.
• The company's participation in the Canaccord Genuity 44th Annual Growth Conference likely generated positive investor sentiment and highlighted Natera's strategic initiatives and future growth prospects.
• The live webcast of the event provided investors with an opportunity to gain insights into Natera's advancements in cell-free DNA testing, potentially driving further interest and investment in the company.

09.07.2024 - NTRA Stock was up 6.8%

• Natera reported a Q2 loss but surpassed revenue estimates, indicating strong performance and potential growth prospects.
• The stock has outperformed the market over the past 5 years, showcasing consistent growth and investor confidence.
• Participation in the Canaccord Genuity 44th Annual Growth Conference suggests Natera's commitment to showcasing its strategies and growth prospects, which might have positively influenced investor sentiment.
• Overall, the combination of positive financial results, long-term market outperformance, and active participation in industry events likely contributed to the bullish movement in Natera's stock today.